8:30 pm – 8:40 pm:

Opening and Welcome Remarks:

Sujuan Ba, Ph.D., President & CEO of NFCR, Co-Founder of AIM-HI & Founder of AFCR

Webster K. Cavenee, Ph.D., Chair of NFCR Scientific Advisory Board; Distinguished Professor Emeritus, University of California, San Diego

8:40 pm – 9:10 pm:

Keynote Speech:

James P. Allison, Ph.D., Professor & Chair of Immunology, Executive Director of Immunotherapy Platform, The University of Texas MD Anderson Cancer Center

9:10 pm – 10:30 pm:

Moderator: Suzanne Topalian, M.D., Professor of Oncology and Surgery, Johns Hopkins University

Panel Members:

• Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard
• Avery D. Posey, Ph.D., Assistant Professor, University of Pennsylvania Perelman School of Medicine
• Azra Raza, M.D., Chan Soon-Shiong Professor of Medicine, Columbia University in New York
• Pam Sharma, M.D., Ph.D., Professor of Genitourinary Medical Oncology and Immunology, The University of Texas MD Anderson Cancer Center
• Thea D. Tlsty, Ph.D., Professor of Pathology, University of California San Francisco

10:45 pm – 11:35 pm:

Moderator: Brian Leyland-Jones, MBBS, Ph.D., Chief Medical Officer & Board Director, NFCR

Panel Members: 

• Lon Cardon, Ph.D., President and CEO, The Jackson Laboratory
• Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics, Harvard Medical School
• Anna D. Barker, Ph.D., Chief Strategy Officer, Ellison Institute for Transformative Medicine
• Min Li, Ph.D., Professor of Medicine, Surgery and Cell Biology, The University of Oklahoma
• Massimo Cristofanilli, M.D., Chief, Breast Medical Oncology, Weil Cornell Medicine

11:35 pm – 12:30 am:

Moderator: Douglas R. Lowy, M.D., Principal Deputy Director, National Cancer Institute

Panel Members:

• Carlo M. Croce, M.D., John W. Wolfe Chair in Human Cancer Genetics, The Ohio State University
• Webster K. Cavenee, Ph.D., Distinguished Professor Emeritus, University of California, San Diego
• Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School
• Steven A. Rosenberg, M.D., Ph.D., Chief, Surgery Branch, National Cancer Institute
• Peter K. Vogt, Ph.D., Professor Emeritus of Molecular Medicine, Scripps Research

1:00 am – 1:40 am:

Emcee: Rose Wang, MBA, Board Director of AIM-HI; Founder & CEO of 1104 Health

Welcome Remarks:

Sujuan Ba, Ph.D., President & CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2023 Beacon Award Selection Committee

Introduction of the 2023 Beacon Award Recipient:

Patty Obermaier, MBA, Nominator of the 2023 Beacon Award Recipient; Emerging Growth Officer, Global Health and Life Sciences, Microsoft

Presenting the Beacon Award Medallion to the Recipient by the Award Selection Committee Members

2023 Beacon Award Winner Award Speech:

Monica M. Bertagnolli, M.D., Director, National Cancer Institute

1:40 am – 2:20 am:

Pamela Garzone, Ph.D., Co-Chair of the Competition Selection & Judging Committees; Chief Development Officer of Anixa Biosciences

Dimitra Georganopoulou, Ph.D.,Co-Chair of the Competition Investment Committee; General Partner of Qral Ventures

• First Prize: Sarah Hein, Ph.D., Co-Founder & CEO of March Biosciences
• Second Prize: Lily Zou, Ph.D., MBA, CEO & Co-Founder of Degron Therapeutics

2:35 am – 3:25 am:

Moderator: Matt Tremblay, Ph.D., Chair of the Board, AIM-HI; CEO of Blackbird Laboratories

• Ignacio Asial, Ph.D., Founder & CEO of DotBio
• Stacy Blain, Ph.D., Co-Founder, CSO & Acting CEO of Concarlo Therapeutics
• Jeremiah Johnson, Ph.D., Co-Founder, Chair – Scientific Advisory Board, & Director of Window Therapeutics
• John Luk, DMedSc, EMBA, CEO of Arbele Bio
• Andrea van Elsas, Ph.D., CSO of ManaT Bio

3:25 am – 3:30 am:

Closing Remarks:

Matt Tremblay, Ph.D., Chair of the Board, AIM-HI; CEO of Blackbird Laboratories

6:00 am – 7:00 am:

Cocktail Reception

7:00 am – 9:00 am:

Szent-Györgyi Prize Dinner Award Ceremony

Moment of Silence

Opening and Welcome Remarks:

Sujuan Ba, Ph.D., President & CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2023 Selection Committee for the Szent-Györgyi Prize

Keynote Speech:

Helmut Sies, M.D., Professor Emeritus, Department of Biochemistry and Molecular Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Introduction of the 2023 Szent-Györgyi Prize Winner:

Rakesh K. Jain, Ph.D., 2022 Szent-Györgyi Prize Winner & Chair of the 2023 Selection Committee for the Szent-Györgyi Prize; Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School; Director, Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital

Award Trophy Presentation:

Sujuan Ba, Ph.D., Co-Chair of the 2023 Selection Committee for the Szent-Györgyi Prize

2023 Szent-Györgyi Prize Winner Award Speech:

Isaac P. Witz, Ph.D., Professor Emeritus at Tel Aviv University; Head of the Laboratory of Tumor Microenvironment & Metastasis Research at The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences

Acknowledgments & Closing Remarks:

Alfred Slanetz, Ph.D., Chair of the Board, NFCR; CEO of Geneius Biotechnology